MAPK3 and left ventricular hypertrophy: Given the numerous human and animal studies identifying PKC and ERK1/2 as critical mediators of left ventricular hypertrophy [6-12], and the aforementioned studies, we hypothesized that ERK1/2 and differential PKC isoforms would be activated in RVH secondary to emphysema.